Active components of Chinese-medicinal medicine with weight-losing and hypolipemic actions and its relative medicine

Abstract

The active hypolipemic components in 40 Chinese-medicinal materials and their relative medicines are disclosed. Said active components can suppress the activity of fatty acid synthetase and the differentiation from profat cells to fat cells and activate the activity of acyl-CoA synthetase. Said medicines feature high effect and low toxic by-effect.

Description

Technical field:

[0001] The invention belongs to the technical field of natural medicines, in particular to a composition for weight loss and fat reduction. Background technique:

[0002] Obesity is a worldwide medical problem. A large amount of evidence has shown that obesity is closely related to various diseases, such as hypertension, hyperlipidemia, diabetes, cardiovascular and cerebrovascular diseases, breast cancer, female infertility, and mental retardation in children. Taking BMI (Body Mass Index) males greater than 27.8 and females greater than 27.3 as the obesity standard, the total number of obese people aged 18-74 in my country is about 70 million, accounting for 5.8% of the total population; the total number of obese people in the same age population in the United States is about 6800 million, accounting for 20% of the total population. my country's annual consumption for weight loss and obesity-related diseases is about 10 billion yuan, while that of the Unite...